Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Fuerst

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Biotechnology and Bioengineering|July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived ProteinFrances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
Journal of Functional Biomaterials|January 20, 2023
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal ChallengeAndrey Romanyuk, Ruixue Wang, Alexander Marin, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineagesFang Chen, Yen Thi Kim Nguyen, Yi-Zong Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Nature Communications|February 11, 2026
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitopeHarry T Paul, Jessica L Mimms, Hanna Aboueid, et al.
Communications Biology|March 6, 2021
Engineering subtilisin proteases that specifically degrade active RASYingwei Chen, Eric A Toth, Biao Ruan, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Biotechnology and Bioengineering|July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived ProteinFrances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
Journal of Functional Biomaterials|January 20, 2023
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal ChallengeAndrey Romanyuk, Ruixue Wang, Alexander Marin, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineagesFang Chen, Yen Thi Kim Nguyen, Yi-Zong Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Nature Communications|February 11, 2026
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitopeHarry T Paul, Jessica L Mimms, Hanna Aboueid, et al.
Communications Biology|March 6, 2021
Engineering subtilisin proteases that specifically degrade active RASYingwei Chen, Eric A Toth, Biao Ruan, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Pageof 5